Accuracy of a Machine-Learning Algorithm for Detecting and Classifying Choroidal Neovascularization on Spectral-Domain Optical Coherence Tomography

Deep learning for unsupervised domain adaptation in medical imaging: Recent advancements and future perspectives

Deep learning has demonstrated remarkable performance across various tasks in medical imaging. However, these approaches primarily focus on supervised learning, assuming that the training and testing data are drawn from the same distribution. Unfortunately, this assumption may not always hold true in practice. To address these issues, unsupervised domain adaptation (UDA) techniques have been developed to transfer knowledge from a labeled domain to a related but unlabeled domain. In recent years, significant advancements have been made in UDA, resulting in a wide range of methodologies, including feature alignment, image translation, self-supervision, and disentangled representation methods, among others. In this paper, we provide a comprehensive literature review of recent deep UDA approaches in medical imaging from a technical perspective. Specifically, we categorize current UDA research in medical imaging into six groups and further divide them into finer subcategories based on the different tasks they perform. We also discuss the respective datasets used in the studies to assess the divergence between the different domains. Finally, we discuss emerging areas and provide insights and discussions on future research directions to conclude this survey.

Machine Learning to Predict Response to Ranibizumab in Neovascular Age-Related Macular Degeneration

Purpose

Neovascular age-related macular degeneration (nAMD) shows variable treatment response to intravitreal anti-VEGF. This analysis compared the potential of different artificial intelligence (AI)-based machine learning models using OCT and clinical variables to accurately predict at baseline the best-corrected visual acuity (BCVA) at 9 months in response to ranibizumab in patients with nAMD.

Design

Retrospective analysis.

Participants

Baseline and imaging data from patients with subfoveal choroidal neovascularization secondary to age-related macular dengeration.

Methods

Baseline data from 502 study eyes from the HARBOR (NCT00891735) prospective clinical trial (monthly ranibizumab 0.5 and 2.0 mg arms) were pooled; 432 baseline OCT volume scans were included in the analysis. Seven models, based on baseline quantitative OCT features (Least absolute shrinkage and selection operator [Lasso] OCT minimum [min], Lasso OCT 1 standard error [SE]); on quantitative OCT features and clinical variables at baseline (Lasso min, Lasso 1SE, CatBoost, RF [random forest]); or on baseline OCT images only (deep learning [DL] model), were systematically compared with a benchmark linear model of baseline age and BCVA. Quantitative OCT features were derived by a DL segmentation model on the volume images, including retinal layer volumes and thicknesses, and retinal fluid biomarkers, including statistics on fluid volume and distribution.

Main Outcome Measures

Prognostic ability of the models was evaluated using coefficient of determination (R²) and median absolute error (MAE; letters).

Results

In the first cross-validation split, mean R² (MAE) of the Lasso min, Lasso 1SE, CatBoost, and RF models was 0.46 (7.87), 0.42 (8.43), 0.45 (7.75), and 0.43 (7.60), respectively. These models ranked higher than or similar to the benchmark model (mean R², 0.41; mean MAE, 8.20 letters) and better than OCT-only models (mean R²: Lasso OCT min, 0.20; Lasso OCT 1SE, 0.16; DL, 0.34). The Lasso min model was selected for detailed analysis; mean R² (MAE) of the Lasso min and benchmark models for 1000 repeated cross-validation splits were 0.46 (7.7) and 0.42 (8.0), respectively.

Conclusions

Machine learning models based on AI-segmented OCT features and clinical variables at baseline may predict future response to ranibizumab treatment in patients with nAMD. However, further developments will be needed to realize the clinical utility of such AI-based tools.

Financial Disclosures

Proprietary or commercial disclosure may be found after the references.

Recent developments on computer aided systems for diagnosis of diabetic retinopathy: a review

Diabetes is a long-term condition in which the pancreas quits producing insulin or the body's insulin isn't utilised properly. One of the signs of diabetes is Diabetic Retinopathy. Diabetic retinopathy is the most prevalent type of diabetes, if remains unaddressed, diabetic retinopathy can affect all diabetics and become very serious, raising the chances of blindness. It is a chronic systemic condition that affects up to 80% of patients for more than ten years. Many researchers believe that if diabetes individuals are diagnosed early enough, they can be rescued from the condition in 90% of cases. Diabetes damages the capillaries, which are microscopic blood vessels in the retina. On images, blood vessel damage is usually noticeable. Therefore, in this study, several traditional, as well as deep learning-based approaches, are reviewed for the classification and detection of this particular diabetic-based eye disease known as diabetic retinopathy, and also the advantage of one approach over the other is also described. Along with the approaches, the dataset and the evaluation metrics useful for DR detection and classification are also discussed. The main finding of this study is to aware researchers about the different challenges occurs while detecting diabetic retinopathy using computer vision, deep learning techniques. Therefore, a purpose of this review paper is to sum up all the major aspects while detecting DR like lesion identification, classification and segmentation, security attacks on the deep learning models, proper categorization of datasets and evaluation metrics. As deep learning models are quite expensive and more prone to security attacks thus, in future it is advisable to develop a refined, reliable and robust model which overcomes all these aspects which are commonly found while designing deep learning models.